Liver Fluke Induces Cholangiocarcinoma

The authors discuss the molecular pathogenesis of opisthorchiasis and associated cholangiocarcinogenesis, particularly nitrative and oxidative DNA damage and the clinical manifestations of cholangiocarcinoma.

[1]  H. Sriplung,et al.  Epidemiology of liver cancer: an overview. , 2004, Asian Pacific journal of cancer prevention : APJCP.

[2]  D. Flavell,et al.  Opisthorchis viverrini: pathogenesis of infection in immunodeprived hamsters , 1986, Parasite immunology.

[3]  S. Srianujata,et al.  High urinary excretion of nitrate and N-nitrosoproline in opisthorchiasis subjects. , 1987, IARC scientific publications.

[4]  Dickson D. Despommier,et al.  Parasitic Diseases , 1989, Springer US.

[5]  K. Yi,et al.  Liver carcinoma and liver fluke infection. , 1984 .

[6]  O. Yamamoto,et al.  cDNA clones of Japanese hepatitis C virus genomes derived from a single patient show sequence heterogeneity. , 1991, Journal of General Virology.

[7]  B. Sripa,et al.  Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis. , 2000, International journal for parasitology.

[8]  H. Bartsch,et al.  opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in thailand , 1991, International journal of cancer.

[9]  E. Kuipers,et al.  Pathogenesis of Helicobacter pylori Infection , 2006, Clinical Microbiology Reviews.

[10]  G. Gores,et al.  Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. , 2001, Gastroenterology.

[11]  S. Tannenbaum,et al.  Nitrosation of amines by stimulated macrophages. , 1987, Carcinogenesis.

[12]  Robin B Gasser,et al.  Clonorchiasis: a key foodborne zoonosis in China. , 2005, The Lancet. Infectious diseases.

[13]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[14]  H. Bartsch,et al.  Endogenous nitrosamines and liver fluke as risk factors for cholangiocarcinoma in Thailand. , 1991, IARC scientific publications.

[15]  B. C. Wong,et al.  Helicobacter pylori infection and gastric cancer. , 1999, Hong Kong medical journal = Xianggang yi xue za zhi.

[16]  J. H. Lim,et al.  Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. , 2003, AJR. American journal of roentgenology.

[17]  P. Sithithaworn,et al.  Liver flukes and liver cancer , 1999 .

[18]  P. Hou,et al.  Chorionepithelioma: an analytical study of 28 necropsied cases, with special reference to the possibility of spontaneous retrogression. , 1956, The Journal of pathology and bacteriology.

[19]  G. Gores,et al.  Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. , 2000, Cancer research.

[20]  S. Oikawa,et al.  iNOS‐dependent DNA damage via NF‐κB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel , 2006, International journal of cancer.

[21]  J. Chai,et al.  Prevalence of intestinal parasite infections on a national scale among primary schoolchildren in Laos , 2003, Parasitology Research.

[22]  M. Haswell-Elkins,et al.  Reversal of biliary tract abnormalities associated with Opisthorchis viverrini infection following praziquantel treatment. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  T. Akaike,et al.  8-nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. , 2006, Antioxidants & redox signaling.

[24]  N. Bhamarapravati,et al.  Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini. , 1978, The American journal of tropical medicine and hygiene.

[25]  J. Reeders,et al.  Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  Erik Schrumpf,et al.  Diagnosis and treatment of cholangiocarcinoma , 2004, Current gastroenterology reports.

[27]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[28]  P. Jongsuksuntigul,et al.  Opisthorchiasis control in Thailand. , 2003, Acta tropica.

[29]  G. Gores,et al.  Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism. , 2002, Cancer research.

[30]  Y. Oshima,et al.  Differences in the drug-metabolizing enzyme activities among fish and bivalves living in waters near industrial and non-industrial areas , 1994, Bulletin of environmental contamination and toxicology.

[31]  Y. I. Kim.  Liver carcinoma and liver fluke infection. , 1984, Arzneimittel-Forschung.

[32]  J. Chai,et al.  Mixed infections with Opisthorchis viverrini and intestinal flukes in residents of Vientiane Municipality and Saravane Province in Laos , 2005, Journal of helminthology.

[33]  W. Brockelman,et al.  Relationship between prevalence and intensity of Opisthorchis viverrini infection, and clinical symptoms and signs in a rural community in north-east Thailand. , 1984, Bulletin of the World Health Organization.

[34]  N. Bhamarapravati,et al.  Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. , 1978, Cancer research.

[35]  M. Haswell-Elkins,et al.  Cholangiocarcinoma in north-east Thailand , 1990, The Lancet.

[36]  M. Haswell-Elkins,et al.  A high frequency of hepatobiliary disease and suspected cholangiocarcinoma associated with heavy Opisthorchis viverrini infection in a small community in north-east Thailand. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[37]  M. Haswell-Elkins,et al.  Relationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonography , 1992, Journal of gastroenterology and hepatology.

[38]  T. Harinasuta,et al.  Opisthorchis viverrini infection: pathogenesis and clinical features. , 1984, Arzneimittel-Forschung.

[39]  P. Pisani,et al.  Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand , 2004, Tropical medicine & international health : TM & IH.

[40]  R. Semba,et al.  Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. , 2004, Nitric oxide : biology and chemistry.

[41]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[42]  S. Hanai,et al.  Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand , 2005, International journal of cancer.

[43]  H. Adami,et al.  Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.

[44]  Hou Pao-Chang,et al.  Chorionepithelioma: an analytical study of 28 necropsied cases, with special reference to the possibility of spontaneous retrogression. , 1956 .

[45]  B. Sripa,et al.  Relationship between parasite‐specific antibody responses and intensity of Opisthorchis viverrini infection in hamsters , 2000, Parasite immunology.

[46]  Y. Hiraku,et al.  Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. , 2006, Antioxidants & redox signaling.

[47]  E. Tabor.  Hepatitis C virus and hepatocellular carcinoma. , 1992, AIDS research and human retroviruses.

[48]  S. Tannenbaum,et al.  DNA damage and mutation in human cells exposed to nitric oxide in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Prinz,et al.  Pathogenesis of Helicobacter pylori infection , 2002, Helicobacter.

[50]  M. Olnes,et al.  A Review and Update on Cholangiocarcinoma , 2004, Oncology.

[51]  H. Rim.  Clonorchiasis: an update , 2005, Journal of helminthology.

[52]  M. Miwa,et al.  Increased cell proliferation of mouse fibroblast NIH-3T3 in vitro induced by excretory/secretory product(s) from Opisthorchis viverrini , 2004, Parasitology.

[53]  J. Vauthey,et al.  Recent Advances in the Management of Cholangiocarcinomas , 1994, Seminars in liver disease.

[54]  Alphonse E. Sirica,et al.  Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.

[55]  P. Migasena,et al.  Nitrates and nitrites in local Thai preserved protein foods. , 1980, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[56]  M. Haswell-Elkins,et al.  Immune responsiveness and parasite‐specific antibody levels in human hepatobiliary disease associated with Opisthorchis viverrini infection , 1991, Clinical and experimental immunology.

[57]  R. Tungtrongchitr,et al.  Study on serum bile acids in opisthorchiasis in Thailand. , 1983, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[58]  M. Miwa,et al.  Gene expression profiling defined pathways correlated with fibroblast cell proliferation induced by Opisthorchis viverrini excretory/secretory product. , 2006, World journal of gastroenterology.

[59]  Yusuke Nakamura,et al.  Comparison of gene expression profiles between Opisthorchis viverrini and non‐Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma , 2006, Hepatology.

[60]  T. Harinasuta,et al.  Clinical and laboratory evaluation of praziquantel in opisthorchiasis. , 1983, The Southeast Asian journal of tropical medicine and public health.

[61]  R. Semba,et al.  Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. , 2004, Carcinogenesis.

[62]  P. Ostrosky-Wegman,et al.  Role of infectious diseases in human carcinogenesis , 2005, Environmental and molecular mutagenesis.

[63]  Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. , 1994, IARC monographs on the evaluation of carcinogenic risks to humans.

[64]  D. Bunnag,et al.  Characterization of humoral immune response in the serum and bile of patients with opisthorchiasis and its application in immunodiagnosis. , 1988, The American journal of tropical medicine and hygiene.

[65]  P. Srivatanakul.  Epidemiology of Liver Cancer in Thailand. , 2001, Asian Pacific journal of cancer prevention : APJCP.

[66]  M. Büchler,et al.  Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[67]  H. Esumi,et al.  Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis. , 1994, Mutation research.

[68]  B. Sripa.  Pathobiology of opisthorchiasis: an update. , 2003, Acta tropica.

[69]  J. Utzinger,et al.  Emerging Foodborne Trematodiasis , 2005, Emerging infectious diseases.

[70]  M. Haswell-Elkins,et al.  Parasite-associated morbidity: liver fluke infection and bile duct cancer in northeast Thailand. , 1994, International journal for parasitology.

[71]  R. Semba,et al.  8-nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini. , 2003, Biochemical and biophysical research communications.

[72]  H. Bartsch,et al.  Relationships between the synthesis of N-nitrosodimethylamine and immune responses to chronic infection with the carcinogenic parasite, Opisthorchis viverrini, in men. , 1998, Carcinogenesis.

[73]  C. Harinasuta,et al.  Opisthorchis viverrini: life cycle, intermediate hosts, transmission to man and geographical distribution in Thailand. , 1984, Arzneimittel-Forschung.